Manuscript review completed with 72/100 readiness score and 4 desk-reject blockers identified
Source type:
obs· Harvested: 2026-05-04 · Original date: 2026-05-04T02:13:10.914Z Metadata:{"project":"oncology-fih-research/oncology-fih-research","type":"discovery","obs_id":65302}
obs/65302 · discovery · 2026-05-04T02:13:10.914Z
Manuscript review completed with 72/100 readiness score and 4 desk-reject blockers identified
The automated Claude Opus review of the JHO manuscript completed after analyzing draft-v3-jho.md, all tables, figures, and the data freeze document. The review assigned a 72/100 submission-readiness score and identified a hierarchical fix list: 4 P0 blockers that prevent submission (missing author email will literally block the online submission system), 4 P1 strongly-recommended improvements (hema-onc specific framing to strengthen journal fit), and 3 P2 anticipated second-round reviewer questions. The review validated internal data consistency across all tables and figures, confirming that deduplication counts, sponsor breakdowns, and modality overlaps are mathematically consistent. However, it flagged Reference 12 as high-risk for LLM fabrication and recommended running pubmed-validator on all references. The core strategic finding is that single-author descriptive registry analyses face higher desk-reject rates at high-impact hematology-oncology journals; the review recommends either adding a senior co-author or redirecting to BMC Cancer/Cancer Medicine where single-author observational studies have better acceptance rates. The review concluded with actionable next steps: complete P0+P1 fixes (8 items), then run cursor agent for second-opinion review before JHO submission.
Concepts: [“what-changed”,“gotcha”,“problem-solution”]
Facts: [“Overall submission-readiness score assessed at 72/100 with potential to reach 86/100 after P0+P1 fixes plus senior co-author addition”,“Four P0 (blocking) issues identified: missing email on line 8, all 25 references lack DOI, STROBE checklist absent, old figure files not archived”,“Data integrity validated: sponsor era totals sum correctly (19+77+206+702=1004), Table 7 vs Table 4 discrepancy (37 vs 34) explained by non-exclusive tagging”,“Reference 12 (Wages NA, JCO Precis Oncol 2024) flagged as high LLM-fabrication risk requiring pubmed-validator verification”,“Single-author descriptive registry analysis identified as scope-fit risk for Journal of Hematology & Oncology (IF 28+), alternative journals BMC Cancer or Cancer Medicine recommended”,“Component scores: figures/data 95, methods transparency 85, AI disclosure 90, authorship metadata 50, journal fit 60, references 65, STROBE 0, housekeeping 55”]
[← 回 Alfred Brain Hub]